Ginkgo Bioworks Lifts Guidance After Mixed Q2 Results; Shares Surge By Investing.com | The Markets Café
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
Tuesday, March 21, 2023
No Result
View All Result
Subscribe
  • Login
The Markets Café
en English
zh-CN 简体中文en Englishfr Françaisde Deutschhi हिन्दीit Italianoja 日本語pt Portuguêsru Русскийes Españoltr Türkçe
  • News
  • Politics
  • Markets
    • Stocks
    • Futures
    • Commodities
  • Crypto
    • News
    • Markets
    • NFT
    • DeFi
    • Explained
  • Economy
  • Finance
  • Investing
  • Forex
  • Real Estate
  • Tech
  • VideosHOT
  • Community
  • Charts
  • News
  • Politics
  • Markets
    • Stocks
    • Futures
    • Commodities
  • Crypto
    • News
    • Markets
    • NFT
    • DeFi
    • Explained
  • Economy
  • Finance
  • Investing
  • Forex
  • Real Estate
  • Tech
  • VideosHOT
  • Community
  • Charts
No Result
View All Result
The Markets Café
No Result
View All Result
  • News
  • Politics
  • Markets
  • Crypto
  • Economy
  • Finance
  • Forex
  • Investing
  • Tech
  • Videos
  • Community
Home Markets Stocks

Ginkgo Bioworks Lifts Guidance After Mixed Q2 Results; Shares Surge By Investing.com

by Press Room
August 16, 2022
in Stocks
98 5
A A
0
21
SHARES
687
VIEWS
FacebookTwitter
© Reuters.

By Yasin Ebrahim

Investing.com — Ginkgo Bioworks lifted its full-year guidance after reporting mixed second-quarter results. Losses were wider than expected as rising costs offset better-than-expected revenue. 

Ginkgo Bioworks Holdings (NYSE:) stock was up more than 17% in aftermarket hours following the report.

The biotech company a loss of 41 cents, compared with Wall Street estimates for a loss of 14 cents. Revenue of $144.6 million topped estimates of $77.6 million.

Total operation expenses swelled to $791.5 million from $103.6 million a year earlier, driven by a surge in research and development costs and general and administrative expenses. 

Looking ahead, the company lifted its forecast for revenue to a range of $425 million to $440 million from $375 million to $390 million, compared with estimates of $384.5 million. 

Ahead of its pending acquisitions of Zymergen and Bayer (OTC:)’s West Sacramento agricultural biologicals R&D facility, the company said the deals were expected to “significantly improve our platform and drive future value.”

The Zymergen transaction is expected to close by Q1 2023, while the Bayer deal is expected to close in Q4 2022, it added.

Read the full article here

Related Articles

Stocks

Asia shares bounce gingerly as bank fears linger By Reuters

March 21, 2023
Stocks

Goldman Sachs sees risk of ‘permanent destruction’ in demand for AT1 bonds By Reuters

March 21, 2023
Stocks

Putin meets ‘dear friend’ Xi in Kremlin as Ukraine war grinds on By Reuters

March 21, 2023
Stocks

PIMCO lost $340 million with Credit Suisse AT1 bonds write-off – source By Reuters

March 21, 2023
Stocks

How Credit Suisse has evolved over 167 years By Reuters

March 21, 2023
Stocks

Walmart pumps $200 million in Indian fintech PhonePe in ongoing fundraise By Reuters

March 21, 2023

About Us

The Markets Café

The Markets Cafe is your one stope Finance, Politics and bussines news website, follow us to get the latest news and updates from around the world.

Sections

  • Commodities
  • Crypto Markets
  • Crypto News
  • DeFi
  • Economy
  • Explained
  • Finance
  • Forex
  • Futures
  • Investing
  • Markets
  • News
  • NFT
  • Politics
  • Real Estate
  • Stocks
  • Tech
  • Videos

Site Links

  • Contact
  • Advertise
  • DMCA
  • Submit Article
  • Forum
  • Site info
  • Newsletter

Newsletter

THE MOST IMPORTANT FINANCE NEWS AND EVENTS OF THE DAY

Subscribe to our mailing list to receives daily updates direct to your inbox!

  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact

© 2022 The Markets Café - All rights reserved.

No Result
View All Result
  • News
  • Politics
  • Markets
    • Stocks
    • Futures
    • Commodities
  • Crypto
    • News
    • Markets
    • NFT
    • DeFi
    • Explained
  • Economy
  • Finance
  • Investing
  • Forex
  • Real Estate
  • Tech
  • Videos
  • Community
  • Charts

© 2022 The Markets Café - All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.